Oroxylin A inhibited autoimmune hepatitis-induced liver injury and shifted Treg/Th17 balance to Treg differentiation-Reference-Cited by-同舟云学术

Oroxylin A inhibited autoimmune hepatitis-induced liver injury and shifted Treg/Th17 balance to Treg differentiation

Published:2023 Issue:3 Volume:72 Page:367-378
ISSN:1341-1357
Container-title:Experimental Animals
language:en
Short-container-title:Exp. Anim.

Author:

Zhu Jinxia¹,Chen Hongxiu¹,Cui Jianjiao²,Zhang Xiaorui²,Liu Guangwei²

Affiliation:

1. The First Clinical Medical College, Henan University of Chinese Medicine, 156 Jinshui East Road, Zhengzhou, Henan, 450046, P.R. China

2. Spleen, Stomach and Hepatobiliary Department, The First Affiliated Hospital of Henan University of Chinese Medicine, No. 19, Renmin Road, Zhengzhou, Henan, 450003, P.R. China

Publisher

Japanese Association for Laboratory Animal Science

Subject

General Veterinary,General Biochemistry, Genetics and Molecular Biology,Animal Science and Zoology,General Medicine

Link

https://www.jstage.jst.go.jp/article/expanim/72/3/72_22-0171/_pdf

Reference73 articles.

1. 1. Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis--Update 2015. J Hepatol. 2015; 62:(Suppl): S100–S111.

2. 2. Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol. 2011; 55: 171–182.

3. 3. Taubert R, Hupa-Breier KL, Jaeckel E, Manns MP. Novel therapeutic targets in autoimmune hepatitis. J Autoimmun. 2018; 95: 34–46.

4. 4. Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, et al. Autoimmune hepatitis. Nat Rev Dis Primers. 2018; 4: 18017.

5. 5. Tanaka A, Mori M, Matsumoto K, Ohira H, Tazuma S, Takikawa H. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan. Hepatol Res. 2019; 49: 881–889.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-326 sponges TET2 triggering imbalance of Th17/Treg differentiation to exacerbate pyroptosis of hepatocytes in concanavalin A-induced autoimmune hepatitis;Annals of Hepatology;2024-03

2. Oroxylin A: Nature's arsenal against liver fibrosis, cancer, and inflammatory diseases;Health Sciences Review;2024-03

3. CD4+ T-cell subsets in autoimmune hepatitis: A review;Hepatology Communications;2023-09-11